Book sale: Save up to 25% on print and eBooks. No promo code needed.
Save up to 25% on print and eBooks.
Essentials of Stem Cell Biology
3rd Edition - August 31, 2013
Editors: Robert Lanza, Anthony Atala
Hardback ISBN:9780124095038
9 7 8 - 0 - 1 2 - 4 0 9 5 0 3 - 8
eBook ISBN:9780124104273
9 7 8 - 0 - 1 2 - 4 1 0 4 2 7 - 3
First developed as an accessible abridgement of the successful Handbook of Stem Cells, Essentials of Stem Cell Biology serves the needs of the evolving population of scientists,… Read more
Purchase Options
LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
First developed as an accessible abridgement of the successful Handbook of Stem Cells, Essentials of Stem Cell Biology serves the needs of the evolving population of scientists, researchers, practitioners, and students embracing the latest advances in stem cells. Representing the combined effort of 7 editors and more than 200 scholars and scientists whose pioneering work has defined our understanding of stem cells, this book combines the prerequisites for a general understanding of adult and embryonic stem cells with a presentation by the world's experts of the latest research information about specific organ systems. From basic biology/mechanisms, early development, ectoderm, mesoderm, endoderm, and methods to the application of stem cells to specific human diseases, regulation and ethics, and patient perspectives, no topic in the field of stem cells is left uncovered.
Contributions by Nobel Laureates and leading international investigators
Includes two entirely new chapters devoted exclusively to induced pluripotent stem (iPS) cells written by the scientists who made the breakthrough
Edited by a world-renowned author and researcher to present a complete story of stem cells in research, in application, and as the subject of political debate
Presented in full color with a glossary, highlighted terms, and bibliographic entries replacing references
researchers, grad students, and professionals working with human stem cells in biology, tissue engineering, genetics, cancer research, virology, immunology, and biotechnology
Cover image
Title page
Table of Contents
Copyright
Foreword
Preface
List of Contributors
Part I: Introduction to Stem Cells
Chapter 1. Why Stem Cell Research? Advances in the Field
1.1 The Origins of Stem Cell Technology
1.2 Organizations that Advocate and Support the Growth of the Stem Cell Sector
1.3 Applications of Stem Cells in Medicine
1.4 Challenges to the Use of Stem Cells
For Further Study
Chapter 2. ‘Stemness’: Definitions, Criteria, and Standards
2.1 What is a Stem Cell?
2.2 Self-Renewal
2.3 Potency
2.4 Clonality
2.5 Definition
2.6 Where do Stem Cells Come from?
2.7 Stem Cells of the Early Embryo
2.8 Ontogeny of Adult Stem Cells
2.9 How are Stem Cells Identified, Isolated, and Characterized?
2.10 Embryonic Stem Cells
2.11 Adult Stem Cells
2.12 Stemness: Progress Toward a Molecular Definition of Stem Cells
Acknowledgments
For Further Study
Chapter 3. Pluripotent Stem Cells from Vertebrate Embryos: Present Perspective and Future Challenges
3.1 Introduction
3.2 Biology of ES and ESL Cells
3.3 Stem Cell Therapy
3.4 Summary
For Further Study
Chapter 4. Embryonic Stem Cells in Perspective
4.1 Embryonic Stem Cells in Perspective
For Further Study
Chapter 5. The Development of Epithelial Stem Cell Concepts
31.6 ‘Global’ Cell Replacement Using Neural Stem Cells
31.7 Neural Stem Cells Display an Inherent Mechanism for Rescuing Dysfunctional Neurons
31.8 Neural Stem Cells as the Glue That Holds Multiple Therapies Together
31.9 Summary
For Further Study
Chapter 32. Adult Progenitor Cells as a Potential Treatment for Diabetes
32.1 Importance of β-Cell Replacement Therapy for Diabetes and the Shortage of Insulin-Producing Cells
32.2 Potential of Adult Stem-Progenitor Cells as a Source of Insulin-Producing Cells
32.3 Defining β-Cells, Stem Cells, and Progenitor Cells
32.4 New β-Cells are Formed Throughout Adult Life
32.5 What is the Cellular Origin of Adult Islet Neogenesis?
32.6 Transdifferentiation of Nonislet Cells to Islet Cells
32.7 Pancreatic Acinar Cell Transdifferentiation
32.8 Bone Marrow Cells as a Source of Insulin-Producing Cells
32.9 Liver as a Source of Insulin-Producing Cells
32.10 Engineering Other Non-β-Cells to Produce Insulin
32.11 Attempts to Deliver Insulin Through Constitutive Rather Than Regulated Secretion
32.12 Summary
For Further Study
Chapter 33. Burns and Skin Ulcers
33.1 Introduction
33.2 Burns and Skin Ulcers – The Problem
33.3 Epidermal Stem Cells
33.4 Stem Cells in Burns and Skin Ulcers – Current Use
33.5 Recent and Future Developments
Acknowledgments
For Further Study
Chapter 34. Stem Cells for the Treatment of Muscular Dystrophy
34.1 Introduction
34.2 Myoblast Transplantation – Past Failure and New Hope
34.3 Unconventional Myogenic Progenitors
34.4 Pluripotent Stem Cells for Future Cell-Based Therapies
34.5 Future Perspectives
Acknowledgments
For Further Study
Chapter 35. Cell Therapy for Liver Disease: From Hepatocytes to Stem Cells
35.1 Introduction
35.2 Background Studies
35.3 Integration of Hepatocytes Following Transplantation
35.4 Clinical Hepatocyte Transplantation
35.5 Hepatocyte Bridge
35.6 Hepatocyte Transplantation in Acute Liver Failure
35.7 Hepatocyte Transplantation for Metabolic Liver Disease
35.8 Hepatocyte Transplantation – Novel Uses, Challenges, and Future Directions
35.9 Conclusion
For Further Study
Chapter 36. Orthopedic Applications of Stem Cells
36.1 Introduction
36.2 Bone
36.3 Cartilage
36.4 Meniscus
36.5 Ligaments and Tendons
36.6 Spine
36.7 Summary
For Further Study
Chapter 37. Embryonic Stem Cells in Tissue Engineering
37.1 Introduction
37.2 Tissue Engineering Principles and Perspectives
37.3 Limitations and Hurdles of Using ES Cells in Tissue Engineering
37.4 Summary
For Further Study
Part VI: Regulation and Ethics
Chapter 38. Ethical Considerations
38.1 Introduction
38.2 Is it Morally Permissible to Destroy a Human Embryo?
38.3 Should we Postpone hES Cell Research?
38.4 Can We Benefit from Others’ Destruction of Embryos?
38.5 Can We Create an Embryo to Destroy it?
38.6 Should We Clone Human Embryos?
38.7 What Ethical Guidelines Should Govern hES Cell and Therapeutic Cloning Research?
38.8 Summary
For Further Study
Chapter 39. Overview of the FDA Regulatory Process
39.1 Introduction and Chapter Overview
39.2 Brief Legislative History of FDA
39.3 Laws, Regulations, and Guidance
39.4 FDA Organization and Jurisdictional Issues
39.5 Approval Mechanisms and Clinical Studies
39.6 Meetings with Industry, Professional Groups, and Sponsors
39.7 Regulations and Guidance of Special Interest for Regenerative Medicine
39.8 FDA’s Standards Development Program
39.9 Advisory Committee Meetings
39.10 FDA Research and Critical Path Science
39.11 Other Communication Efforts
39.12 Conclusion
For Further Study
Chapter 40. It’s Not about Curiosity, It’s about Cures: Stem Cell Research – People Help Drive Progress
40.1 Choosing Life
40.2 Size of the Promise
40.3 Personal Promises Fuel Progress
40.4 Hope Versus Hype
40.5 Giving Life
40.6 People Drive Progress
40.7 Better Health for All
Glossary
Index
No. of pages: 674
Language: English
Published: August 31, 2013
Imprint: Academic Press
Hardback ISBN: 9780124095038
eBook ISBN: 9780124104273
RL
Robert Lanza
Robert Lanza is an American scientist and author whose research spans the range of natural science, from biology to theoretical physics. TIME magazine recognized him as one of the “100 Most Influential People in the World,” and Prospect magazine named him one of the Top 50 “World Thinkers.” He has hundreds of scientific publications and over 30 books, including definitive references in the fields of stem cells, tissue engineering, and regenerative medicine. He’s a former Fulbright Scholar and studied with polio-pioneer Jonas Salk and Nobel laureates Gerald Edelman (known for his work on the biological basis of consciousness) and Rodney Porter. He also worked closely (and co-authored papers in Science on self-awareness and symbolic communication) with noted Harvard psychologist BF Skinner. Dr. Lanza was part of the team that cloned the world’s first human embryo, the first endangered species, and published the first-ever reports of pluripotent stem cell use in humans.
Affiliations and expertise
Astellas Institute for Regenerative Medicine, Westborough, MA, USA
AA
Anthony Atala
Anthony Atala, MD, is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine, and the W. Boyce Professor and Chair of Urology. Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine. Fifteen applications of technologies developed in Dr. Atala's laboratory have been used clinically. He is Editor of 25 books and 3 journals. Dr. Atala has published over 800 journal articles and has received over 250 national and international patents. Dr. Atala was elected to the Institute of Medicine of the National Academies of Sciences, to the National Academy of Inventors as a Charter Fellow, and to the American Institute for Medical and Biological Engineering.
Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board. He is a founding member of the Tissue Engineering Society, Regenerative Medicine Foundation, Regenerative Medicine Manufacturing Innovation Consortium, Regenerative Medicine Development Organization, and Regenerative Medicine Manufacturing Society.
Affiliations and expertise
Professor, Wake Forest Institute for Regenerative Medicine